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A molecular chaperone activity 
of CCS restores the maturation of 
SOD1 fALS mutants
Enrico Luchinat  1,2, Letizia Barbieri1,3 & Lucia Banci1,4
Superoxide dismutase 1 (SOD1) is an important metalloprotein for cellular oxidative stress defence, 
that is mutated in familiar variants of Amyotrophic Lateral Sclerosis (fALS). Some mutations destabilize 
the apo protein, leading to the formation of misfolded, toxic species. The Copper Chaperone for SOD1 
(CCS) transiently interacts with SOD1 and promotes its correct maturation by transferring copper and 
catalyzing disulfide bond formation. By in vitro and in-cell NMR, we investigated the role of the SOD-
like domain of CCS (CCS-D2). We showed that CCS-D2 forms a stable complex with zinc-bound SOD1 
in human cells, that has a twofold stabilizing effect: it both prevents the accumulation of unstructured 
mutant SOD1 and promotes zinc binding. We further showed that CCS-D2 interacts with apo-SOD1 
in vitro, suggesting that in cells CCS stabilizes mutant apo-SOD1 prior to zinc binding. Such molecular 
chaperone function of CCS-D2 is novel and its implications in SOD-linked fALS deserve further 
investigation.
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by the death of motor 
neurons in the brain and spinal cord. Human copper, zinc superoxide dismutase (SOD1) is a conserved intracel-
lular metalloprotein that protects the cell from oxidative damage. It has been shown that SOD1 is implicated in 
a sizable fraction of the familial variants of ALS (fALS)1. Several missense mutations in the sod1 gene scattered 
throughout the polypeptide of SOD1 have been correlated with the onset of fALS2. These mutations have been 
linked to the formation of amorphous aggregates enriched in SOD1 in the spinal cord of fALS patients and in 
transgenic mice3–6.
In order to reach its active conformation, SOD1 has to undergo several post-translational maturation events in 
the cytoplasm, which include zinc binding, dimerization, copper binding and the formation of an intramolecular 
disulfide bond. All these post-translational events stabilize the fold of SOD1, which in the apo state is intrinsically 
unstable and prone to unfolding and aggregation7,8. Some fALS mutations, termed wild type-like (WT-L), do 
not affect the enzymatic activity of the mature protein, as they do not perturb the geometry of the SOD1 metal 
binding sites, nor the disulfide bond9,10. These mutations however are known to further destabilize the structure 
of the apo protein, increasing the fraction of unfolded protein and eventually leading to misfolding and to the 
formation of the cytotoxic species7,8,11,12.
The molecular events leading the mature, enzymatically active form of SOD1 have been extensively studied 
in vitro. Disulfide-reduced, monomeric apo-SOD1 binds zinc spontaneously, and forms a stable homodimer13,14. 
Copper binding and disulfide bond formation are mediated by a specific partner, the Copper Chaperone for 
SOD1 (CCS)15,16. CCS acts as a metallochaperone through its N-terminal Atx1-like domain (D1) and as oxidore-
ductase through its C-terminal domain (D3), whereas the second, SOD-like domain (D2) is responsible for the 
interaction with SOD115–24. Recently, the maturation steps of SOD1 have been observed in living human cells25 
through in-cell NMR26,27. It has been shown that some WT-L fALS SOD1 mutants fail to bind zinc when they 
are overexpressed in the human cytoplasm, and accumulate as unstructured species that may act as precursors 
in the pathogenic aggregation pathway28. Importantly, this mechanism can be reverted by co-expressing CCS, 
indicating that the copper chaperone is able to pull the nascent SOD1 molecules towards the correct folding and 
maturation pathway.
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Here, we investigated further how CCS exerts this protective role. We characterized by in-cell NMR the inter-
action between CCS and SOD1, both WT and the WT-L fALS mutants A4V, T54R, G93A, I113T, in the cyto-
plasm of living human cells. We showed that the SOD-like domain of CCS, D2, acts as a molecular chaperone 
in the human cytoplasm. D2 alone is sufficient to interact with the immature, metastable state of fALS SOD1 
mutants, and effectively prevents the accumulation of unstructured species. In the absence of D1 and D3, the 
CCS-dependent maturation cannot occur and the SOD1-D2 heterodimer becomes a stable intermediate, whereas 
full-length CCS interacts transiently with SOD1 allowing its complete maturation. In vitro analysis revealed that, 
in the heterodimer observed in cells, SOD1 is in the zinc-bound form. These data suggest that D2 of CCS favours 
zinc binding to mutant SOD1 by interacting either with the zinc-bound protein and preventing zinc dissociation, 
or with the apo protein stabilizing it and allowing zinc binding. In favour of the latter hypothesis, we further 
showed that D2 of CCS is able to interact with apo-SOD1 in vitro, and therefore that CCS acts as a molecular 
chaperone towards the most immature state of SOD1.
Results
CCS-D2 forms a stable heterodimer with zinc-bound WT SOD1. WT SOD1 overexpressed in the 
human cell cytoplasm in the presence of excess zinc is found in a stable intermediate maturation state, i.e. a 
homodimer with one zinc ion bound to each monomer, and all cysteines reduced (henceforth E,Zn-SOD1SH)25. 
This species is free to tumble in the cytoplasm, and gives rise to well resolved signals in the 1H-15N in-cell NMR 
spectra (Fig. 1a). When full-length CCS (FL-CCS) is co-expressed at similar levels, SOD1 maturation proceeds 
further along its pathway: the oxidized zinc-bound SOD1 (E,Zn-SOD1SS) is observed in defect of copper, whereas 
in excess of copper the fully mature protein (Cu,Zn-SOD1SS) is observed25. CCS is not visible in the 1H-15N in-cell 
NMR spectra, with the exception of a few signals (Supplementary Figure S1a), due to interactions with large cel-
lular components such as the plasma membrane29, but is clearly observed in the NMR spectra of the cell lysates 
(Supplementary Figure S1b).
When CCS-D2 was co-expressed with WT SOD1 (95.7 ± 2.6 µM and 118.2 ± 5.4 µM, respectively), the result-
ing in-cell NMR spectra were remarkably different from those of E,Zn-SOD1SH, suggesting the formation of a 
stable complex between SOD1 and CCS-D2 (Fig. 1a). An overall line broadening was observed, and a few signals 
of SOD1 were shifted. Several more signals arising from CCS-D2 were also present. The line broadening observed 
in the in-cell NMR spectra likely arises from the residual interactions of the CCS-D2 monomer with the plasma 
membrane; consistently, CCS-D2 expressed alone was not detected by in-cell NMR (Supplementary Figure S1c,d) 
due to such interactions. Upon cell lysis, the complex between SOD1 and CCS-D2 remained unaltered and gave 
rise to sharp signals in the lysate NMR spectra, with no obvious chemical shift changes with respect to the in-cell 
NMR spectra (Fig. 1b).
Comparison with in vitro NMR spectra acquired on [U-15N]-E,Zn-SOD1SH titrated with 1 equivalent of 
unabelled CCS-D2 (Fig. 1c) confirmed that the intracellular species observed is indeed the complex between 
E,Zn-SOD1SH and CCS-D2. The crosspeaks arising from SOD1 in the complex formed in vitro were in slow 
Figure 1. CCS-D2 forms a stable complex with E,Zn-SOD1SH both in cells and in vitro. (a) 1H-15N NMR 
spectra of human cells expressing [U-15N]-labelled WT SOD1 either alone (red) or together with [U-15N]-
labelled CCS-D2 (black). (b) 1H-15N NMR spectra of the corresponding cell lysates. (c) In vitro 1H-15N NMR 
spectra of [U-15N]-labelled WT SOD1 without (orange) and with 1 equivalent (blue) of unlabelled CCS-D2. 
SOD1 signals experiencing chemical shift changes upon complex formation are labelled in the full spectra 
(upper panels) and in the detailed views (lower panels). See also Supplementary Figures S1 and S2.
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exchange with those of free SOD1 in the presence of sub-stoichiometric CCS-D2 (Supplementary Figure S2). 
15N relaxation analysis on the complex in vitro resulted in a molecular reorientation correlation time (τm) of 
17.2 ± 1.8 ns, estimated from 15N R2/R1 ratios. Such value is close to that reported for the E,Zn-SOD1SH homod-
imer (τm = 20.6 ± 0.9 ns)13 and is consistent with the formation of a 32 kDa heterodimer between SOD1 and 
CCS-D2 (the latter having essentially the same molecular weight of one SOD1 monomer).
Taken together, these data show that CCS-D2 stably interacts with WT E,Zn-SOD1SH in the cytoplasm, form-
ing a heterodimer which is preserved upon cell lysis.
CCS-D2 interacts with and stabilizes fALS SOD1 mutants. As shown previously, some WT-L fALS 
SOD1 mutants do not bind zinc when overexpressed in human cells, and accumulate in the cytoplasm as unstruc-
tured species28. When CCS-D2 was co-expressed with G93A (100.2 ± 4.5 µM and 114.2 ± 1.7 µM, respectively) 
and with I113T (107.1 ± 1.6 µM and 107.4 ± 4.9 µM, respectively) SOD1 mutants, the amount of unstructured 
species was greatly decreased in the in-cell NMR spectra and the signals arising from the heterodimer with 
CCS-D2 were observed (Fig. 2a,b). Also in this case the complex was unaltered upon cell lysis, and no addi-
tional conformations of SOD1 were observed, indicating a stable interaction between mutant SOD1 and CCS-D2 
(Supplementary Figure S3a,b). Chemical shift comparison with the corresponding spectra of WT SOD1, both in 
cells and in the lysate, indicated that the SOD1 mutants in the complex with CCS-D2 have the same conformation 
of WT SOD1 in the same complex, i.e. they have bound zinc (Fig. 2c,d). The only significant chemical shift dif-
ferences are ascribed to the single-point mutations. Also the A4V SOD1 mutant, which is severely destabilized in 
the apo state, was partially stabilized by CCS-D2 (Supplementary Figure S3c). Due to the lower expression levels 
of A4V SOD1 (61.8 ± 2.1 µM) compared to co-expressed CCS-D2 (83.1 ± 8.5 µM) and to the other mutants, addi-
tional signals were observed in the NMR spectra of the lysate arising from an excess of free CCS-D2 homodimer 
(Supplementary Figure S3d).
The interaction between CCS-D2 and T54R SOD1 (80.4 ± 6.5 µM and 85.2 ± 10.0 µM, respectively) was 
also investigated. The T54R mutation does not cause the misfolding of SOD1, but interferes with the disulfide 
bond formation mediated by CCS28. Interestingly, T54R SOD1 also formed a stable complex with CCS-D2 
(Supplementary Figure S4), indicating that the mutation did not affect the interaction with D2 (as it would be 
expected from the structure reported by Lamb et al.18), but likely interferes with the D3-mediated disulfide bond 
formation (consistent with a more recent report by Fetherolf et al.24).
Overall, these data indicate that CCS-D2 interacts with fALS SOD1 mutants in a similar fashion to the WT 
SOD1. CCS-D2 forms a stable heterodimer with mutant SOD1 that is structurally equivalent to the heterodimer 
with the zinc-bound WT SOD1. By doing so, CCS-D2 prevents the formation of the unstructured species in the 
cells, effectively acting as a molecular chaperone.
CCS-D2 interacts with WT apo-SOD1SH in vitro. In order to further elucidate the mechanism 
of action of CCS in stabilizing SOD1, we sought to determine whether CCS-D2 could also interact with the 
disulfide-reduced apo form of SOD1. To this aim, WT [U-15N]-apo-SOD1SH was titrated in vitro with up to 
three equivalents of unlabelled CCS-D2 and monitored by NMR after each addition. The addition of CCS-D2 
caused the disappearance of several well-dispersed NMR signals of the monomeric apo-SOD1SH, together with 
the appearance of broader peaks presumably arising from apo-SOD1SH in the complex with CCS-D2 (Fig. 3a). 
With 1 equivalent of CCS-D2, ~20% of free apo-SOD1SH was still detected; the latter disappeared only in the 
presence of more than 2 equivalents of CCS-D2, suggesting that its affinity for CCS-D2 is lower than that of 
E,Zn-SOD1SH (Fig. 3b,c).
Figure 2. CCS-D2 stabilizes fALS SOD1 mutants and allows zinc binding. (a) 1H-15N NMR spectra of lysates 
from cells expressing [U-15N]-labelled G93A SOD1 alone (green) and together with [U-15N]-labelled CCS-D2 
(black). (b) 1H-15N NMR spectra of lysates from cells expressing [U-15N]-labelled I113T SOD1 alone (magenta) 
and together with [U-15N]-labelled CCS-D2 (black). (c,d) Detailed views of characteristic SOD1 signals in the 
1H-15N NMR spectra of lysates containing [U-15N]-labelled WT SOD1 alone (black), and WT SOD1 (red) and 
mutants G93A, I113T, A4V (green, magenta and azure, respectively) in the complex with CCS-D2, showing 
that SOD1 mutants experience chemical shift changes similar to WT SOD1 upon complex formation. See also 
Supplementary Figure S3.
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15N relaxation analysis performed on the final 1:3 mixture of apo-SOD1SH and CCS-D2 resulted in an esti-
mated τm of 18.6 ± 1.4 ns, obtained by analyzing a set of well-dispersed signals arising mainly from residues in 
the β-barrel of SOD1 (shown in Fig. 3a). Such value is comparable to that of the complex between E,Zn-SOD1SH 
and CCS-D2, and is markedly increased from the τm reported for the monomeric apo-SOD1SH (10.3 ± 0.4 ns)13.
In order to assess whether apo-SOD1SH in the complex with CCS-D2 could bind zinc, the apo-SOD1SH – 
CCS-D2 complex was further titrated with 1 equivalent of zinc per SOD1 monomer. The NMR spectra of the final 
point of the titration revealed that the E,Zn-SOD1SH – CCS-D2 complex had formed (Supplementary Figure S5a), 
identical to that obtained by direct titration of E,Zn-SOD1SH with CCS-D2 (Supplementary Figure S5b and 
Fig. 1c), meaning that interacting with CCS while in the apo state would eventually lead SOD1 towards the same 
maturation pathway observed for the zinc-bound form.
Taken together, these data are consistent with the formation of a heterodimer between apo-SOD1SH and 
CCS-D2 with the same size as that between E,Zn-SOD1SH and CCS-D2. Therefore, CCS-D2 can also bind the 
non-metallated form of SOD1, albeit with lower affinity, possibly contributing to the stabilization effect observed 
in cells, and allowing zinc binding to occur subsequently on the apo-SOD1SH – CCS-D2 complex.
Discussion
fALS-linked SOD1 mutations are known to have several detrimental effects on the folding stability and on the mat-
uration pathway of SOD1. In particular, several wild type-like mutations have been associated to a thermodynamic 
destabilization of SOD1, and have been shown to decrease the conformational stability of the apo, disulfide-reduced 
protein11,30. Furthermore, some mutants have been shown to destabilize the homodimer, due to a reduced associ-
ation constant for the dimer formation31,32. The latter effect contributes to shift the equilibrium in cell towards the 
monomeric state, while the former increases the rate of the formation of the unstructured species. The interaction 
between SOD1 and CCS – mediated by D2 – has been extensively investigated before15–24, and CCS is known to have 
a stabilizing effect on the maturation pathway of SOD1: overexpression of CCS in cell cultures and transgenic mice 
has previously revealed a protective function against the aggregation of mutant SOD133–35. Traditionally, the ability 
of CCS to rescue SOD1 from unfolding and aggregation has been attributed to its metallochaperone and oxidore-
ductase activities (i.e. copper transfer and formation of the disulfide bond), and D2, the SOD-like domain of CCS, 
has been relegated to a simple recognition function, required to allow the formation of the transient SOD1-CCS 
complex. Here we show that CCS-D2 forms a stable complex with mutant SOD1, and by doing so it prevents the 
accumulation of unstructured apo-SOD1 in the cytoplasm. Our observations are consistent with the protective role 
of full-length CCS previously observed in vivo33–35. Compared to SOD1, CCS is expressed at lower levels in living 
organisms36, but its functional complex with immature SOD1 is transient and leads to the formation of fully mature 
SOD1, allowing CCS to be recycled and interact with a new molecule of immature SOD1. Unlike full-length CCS, 
the complex between SOD1 and CCS-D2 obviously cannot proceed towards fully mature SOD1 and becomes the 
end point of the pathway. Such complex is clearly observed by in-cell NMR and corresponds to a SOD1 dimer-like 
heterodimer containing a SOD1 and a CCS-D2 subunit, relatively free to move in the cytosol. Notably, the SOD1 
mutants in the complex with CCS-D2 have bound a zinc ion, and are structurally equivalent to WT E,Zn-SOD1SH in 
the same complex. Therefore, the stabilizing effect of CCS-D2 on mutant SOD1 is twofold: it prevents the accumu-
lation of unstructured apo protein and facilitates zinc binding.
Figure 3. CCS-D2 interacts with apo-SOD1SH in vitro. (a) In vitro 1H-15N NMR spectra of [U-15N]-labelled apo-
SOD1SH alone (black) and in the presence of 2 equivalents of unlabelled CCS-D2 (red). The signals used to estimate 
the molecular reorientation correlation time (τm) of apo-SOD1SH in the complex with CCS-D2 are labelled. (b,c) 
Detailed views of SOD1 signals (red) experiencing chemical shift changes upon titration with 1 (azure) and 2 (red) 
equivalents of CCS-D2, showing that apo-SOD1SH free and in the complex are in the slow exchange regime.
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Based on these observations and on those previously reported, we can summarize the pathway required for 
SOD1 maturation, and qualitatively indicate in which step CCS will positively affect the pathway (Fig. 4). We can 
hypothesize two possible modes of actions for the stabilizing effect of CCS-D2, which are not mutually exclusive: 
one is that zinc binding to SOD1 occurs first, and then CCS interacts with E,Zn-SOD1SH (Fig. 4a). This pathway 
would be most consistent with what observed for WT SOD1, as it is known to bind zinc spontaneously in the 
cytoplasm. In the case of mutant SOD1 however, it would imply that the protein would bind zinc and then, in the 
absence of CCS, lose it.
The other mode of action is that CCS first interacts with monomeric apo-SOD1SH and stabililizes it in a 
homodimer-like folding state, and then apo-SOD1 in the heterodimer binds zinc (Fig. 4b). In order to deter-
mine whether this mechanism occurs in the cell, we would have to separate in time the formation of the het-
erodimer and the zinc binding. However, this is difficult to achieve because cells have to be supplied with zinc 
during protein expression, due to the fact that also CCS-D2 needs zinc to fold correctly. In vitro, on the other 
hand, the two events are easily separated as zinc-containing CCS-D2 can be mixed with apo-SOD1SH. Our data 
show that CCS-D2 indeed interacts with apo-SOD1SH and forms a heterodimer in vitro, albeit with lower affinity 
than with E,Zn-SOD1SH. The NMR signals arising from the folded part of free apo-SOD1SH appeared to be in a 
slow-intermediate exchange regime with the corresponding signals in the complex, implying a dynamic equilib-
rium in the milliseconds time scale, slow enough to allow the conformational rearrangement of SOD1 as a con-
sequence of zinc binding. While the interaction between apo-SOD1SH and CCS-D2 had been reported before22,23, 
its functional role had not been fully recognized and deserves further characterization.
In this work, we showed that the SOD-like domain of CCS acts as a molecular chaperone towards immature 
SOD1 and helps to stabilize the folded state of fALS-linked wild type-like SOD1 mutants, favouring their correct 
maturation within the cell. CCS-D2-mediated stabilization has a twofold effect: it prevents the accumulation of 
unstructured apo species of SOD1, which are the potential precursors of pathogenic forms such as oligomers or 
aggregates, and allows SOD1 to bind zinc, which is a critical step of its maturation towards the enzymatically 
active and structurally stable protein. We showed that in vitro CCS-D2 can interact either with apo-SOD1SH or 
with E,Zn-SOD1SH, with higher affinity for the latter, with which it produces a stable complex that is also observed 
in living cells. While both mechanisms would allow SOD1 to progress through the correct maturation pathway, 
the direct interaction between CCS and apo-SOD1SH gives credit to the hypothesis that CCS stabilizes SOD1 prior 
to zinc binding. The molecular chaperone role of CCS described here adds further depth to our understanding 
of how this protein is critical for the correct maturation of SOD1, and will likely have important implications in 
the context of developing novel strategies for preventing the cytotoxic effects of mutant SOD1 in familial ALS.
Methods
Gene cloning. The cDNA encoding the SOD-like domain of human CCS (amino acids 84–234, Gen 
Bank: NP_005116.1) was amplified by PCR using the primers D2-F (5′-CCGGAATTCGCCACCATGC 
AGAATCTGGGGGCAGCAGTGGCC-3′) and D2-R (5′-ATAACCGCTCGAGAAGCTTTTTAAGC 
GGAGCGTGCAATGATGCCACAG-3′), and cloned into the pHLsec37 vector between EcoRI and XhoI restric-
tion enzyme sites to generate the mammalian expression plasmid. The clone was verified by DNA sequencing. 
pHLsec vectors encoding WT human SOD1 (amino acids 1–154, GenBank: NP_000445.1) and the mutants A4V, 
T54R, G93A and I113T had been generated previously28.
Figure 4. Proposed model for the molecular chaperone activity of CCS-D2. Schematic drawing of the initial 
maturation steps of SOD1 illustrating the role of CCS-D2 in stabilizing immature SOD1. The arrows show the 
preferred direction of each step. Red arrows indicate which maturation steps are negatively influenced by fALS-
SOD1 mutations. Two possible mechanisms of action for CCS-D2 are shown: (a) SOD1 first binds zinc and 
then interacts with CCS-D2; (b) apo-SOD1 first interacts with CCS-D2 and then binds zinc. While the complex 
formed between SOD1 and CCS-D2 is stable and can be observed in the cells, the interaction between SOD1 
and copper-bound FL-CCS (not shown) leads to the fully mature Cu,Zn-SOD1SS protein.
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Human cell culture and transfection. HEK293T (ATCC CRL-3216) cells were maintained in DMEM 
high glucose (Life Technologies) supplemented with L-glutamine (Life Technologies, 2 mM final concentra-
tion), antibiotics (penicillin and streptomycin, Life Technologies, 100 U/ml final concentration) and 10% FBS 
(Gibco) in uncoated 75 cm2 plastic flasks and incubated at 37 °C, 5% CO2 in a humidified atmosphere. Cells were 
transiently transfected with the pHLsec plasmid containing the gene of interest using polyethylenimine (PEI, 
branched, average Mw 25 kDa, Sigma-Aldrich), as previously described38. For co-expression of SOD1 (both WT 
and mutants) and CCS-D2, cells were transfected with plasmids containing the constructs in different amounts 
and ratios. The final ratio was chosen in order to obtain similar expression levels of the two proteins; specifically 
a weight ratio of 1:1:2 (25 µg SOD1 WT or mutant DNA; 25 µg CCS-D2 DNA; 50 µg PEI per 75 cm2 flask) was 
used. [U-15N]-BioExpress6000 medium (Cambridge Isotope Laboratories) was used for in-cell NMR samples, 
supplemented with 2% FBS, antibiotics and 10 µM of ZnSO4.
In-cell NMR sample preparation. Samples for in-cell NMR were prepared following a reported protocol2. 
Briefly, transfected cells were detached with trypsin, suspended in DMEM + 10% FBS, washed once with PBS and 
re-suspended in one pellet volume of DMEM supplemented with 90 mM glucose, 70 mM HEPES and 20% D2O. 
The cell suspension was transferred in a 3 mm Shigemi NMR tube, which was gently spun to sediment the cells 
at the bottom. Cell viability before and after NMR experiments was assessed by trypan blue staining. After the 
NMR experiments, the cells were collected and the supernatant was checked for protein leakage by NMR. The 
cell lysates were prepared by freeze-thaw cycles in PBS buffer followed by centrifugation to remove the insoluble 
fraction. The supernatant was collected for NMR analysis.
Expression and purification of SOD1. WT SOD1 protein was prepared following an existing protocol39. 
Briefly, a cell culture of E. Coli BL21(DE3) Gold (Stratagene), transformed with a pET28a plasmid containing the WT 
SOD1 gene was grown overnight at 37 °C in LB, harvested and re-suspended in 15N-labelled M9 medium. ZnSO4 
was added in the culture to a final concentration of 100 µM. After 4 h from induction with 0.5 mM IPTG at 30 °C the 
cells were harvested and re-suspended in 20 mM Tris, pH 8 buffer for lysis. The cleared lysate was loaded on an anion 
exchange column (HiPrep Q FF 16/10, GE Healthcare) for a first purification by elution with NaCl gradient. The frac-
tions containing SOD1 (checked by SDS-PAGE) were collected and further purified by gel filtration (Superdex 75 26/60 
column, GE Healthcare) in 20 mM Tris, 100 mM NaCl, pH 8 buffer. Fractions containing pure SOD1 were collected. 
1 mM DTT was added in all buffers to prevent protein aggregation mediated by disulfide bonds.
Apo-SOD1SS was produced by repeated dialysis against 10 mM EDTA in 50 mM acetic acid at pH 3.5. Then, 
the buffer was exchanged in phosphate-buffered saline (PBS) pH 7.4. To obtain apo-SOD1SH, apo-SOD1SS was 
incubated 40 min at 37 °C with 50 mM of DTT. Following disulfide bond reduction, the buffer was exchanged to 
remove DTT and dissolved oxygen. E,Zn-SOD1SH was then obtained by adding one equivalent per monomer of 
ZnSO4 in anaerobic conditions. Correct disulfide reduction and metallation were checked by 1H-15N NMR.
Expression and purification of CCS-D2. The synthetic gene encoding CCS-D2 cloned in the pTH34 plas-
mid with an N-terminal histidine tag was obtained previously22. The protein was expressed in E. coli BL21(DE3) 
C41 cells (Stratagene). Protein expression was induced with 0.7 mM IPTG for 16 h at 30 °C. ZnSO4 was added in 
the culture to a final concentration of 100 µM. Purification was performed using a nickel-chelating HiTrap (GE 
Healthcare) column. After digestion with AcTEV protease (Invitrogen) O/N at 25 °C the protein was separated 
from the affinity tag in a HiTrap column. To further separate CCS-D2 from the residual affinity tag, the digested 
protein was loaded on a Superdex 75 26/60 (GE Healthcare) chromatographic column and the fraction containing 
pure CCS-D2 were collected. The buffer was then exchanged in anaerobic conditions to remove dissolved oxygen.
NMR experiments. In-cell NMR spectra were collected at 308 K at a 950 MHz Bruker Avance III spec-
trometer equipped with a TCI CryoProbe. For each cell sample, a 2D 1H-15N SOFAST-HMQC40 spectrum was 
recorded with 64 scans, 2048 points, 128 increments and a 0.3 s recycle delay (duration ~1 h). NMR spectra of the 
corresponding cell lysates were collected at 950 MHz with the same experimental parameters.
In vitro titration of WT [U-15N]-E,Zn-SOD1SH with CCS-D2 was performed at 950 MHz on a sample of 
140 µM E,Zn-SOD1SH in PBS buffer (pH 7.4). Increasing amounts of CCS-D2 in the same buffer were added in 
anaerobic conditions up to 1 equivalent, and 2D 1H-15N SOFAST-HMQC spectra were acquired at 308 K after 
each addition. In vitro titration of WT [U-15N]-apo-SOD1SH with CCS-D2 was performed at a 900 MHz Bruker 
Avance III spectrometer equipped with a TCI CryoProbe. Increasing amounts of CCS-D2 were added to a sample 
of 100 µM apo-SOD1SH in PBS buffer (pH 7.4) under anaerobic conditions, up to three equivalents. 2D 1H-15N 
SOFAST-HMQC spectra were acquired after each addition at 298 K.
In vitro 15N-R1, R2 relaxation experiments were collected on both E,Zn-SOD1SH and apo-SOD1SH – CCS-D2 
complexes at 298 K at a 500 MHz Bruker spectrometer equipped with a TCI CryoProbe. The 15N-R1, R2 values for 
each crosspeak were obtained by fitting the signal intensity at increasing evolution times with mono-exponential 
decays in OriginPro. The molecular reorientation correlation times (τm) for both complexes was estimated from 
the averaged R2/R1 ratio of a subset of well-dispersed crosspeaks that were known to arise from the folded part of 
the protein and exhibited homogeneous relaxation properties.
All the NMR spectra collected were processed with Bruker Topspin NMR data-processing software. The 
in-cell NMR spectra were further processed by subtracting a spectrum of cells transfected with empty vector, 
acquired in the same experimental conditions, to eliminate the signals arising from partial 15N labelling of other 
cellular components.
Protein quantification. The expression levels of WT/mutant SOD1 and CCS-D2 were determined by 
Coomassie-stained SDS-PAGE (Supplementary Figure S6). Lysates from cell samples co-expressing SOD1 
and CCS-D2 were run at increasing dilutions together with purified WT SOD1 and CCS-D2 as references. 
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Densitometry analysis was performed with ImageJ. The values reported in the main text reflect the protein con-
centrations calculated in the cell lysates, which correspond to the effective concentrations in the in-cell NMR 
samples (mean value ± S.E.M.).
Data Availability. All the data generated and analysed during the current study are available from the corre-
sponding author on reasonable request.
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